Huober J, Barrios CH, Niikura N, Jarzab M, et al. Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial. J Clin Oncol 2022 Jun 28:JCO2102772. doi: 10.1200/JCO.21.02772.
PMID: 35763704